New drug trial hopes to ease angelman syndrome symptoms in kids
NCT ID NCT05630066
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called alogabat in 48 children aged 5-17 with Angelman syndrome (a specific genetic type). The goal was to see how the drug moves through the body and if it is safe. Researchers also looked at brain activity changes to see if the drug works as expected. This is not a cure, but aims to control symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGELMAN SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
CHRU de Brest
Brest, 29609, France
-
CHU Dijon Bourgogne Hôpital François Mitterand
Dijon, 21000, France
-
Carolina Institute for Development DisabilitiesUniversity of North Carolina/School of Medicine
Carrboro, North Carolina, 27510, United States
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Corporacio Sanitaria Parc Tauli
Sabadell, Barcelona, 08208, Spain
-
Dr. Von Haunersches Kinderspital
München, 80337, Germany
-
Groupe Hospitalier Necker Enfants Malades
Paris, 75015, France
-
Hopital la Timone Enfants
Marseille, 13005, France
-
Hospital Sant Joan de Deu
Esplugues de Llobregat · Barcelona, Barcelona, 08950, Spain
-
Hospital Universitario Puerta De Hierro Majadahonda
Madrid, 28222, Spain
-
Hospital Universitario de Navarra;Unidad de Neuropediatría
Pamploa, Navarre, 31008, Spain
-
IRCCS Eugenio Medea
Conegliano Veneto (TV), Veneto, 31015, Italy
-
IRCCS Istituto G. Gaslini
Genoa, Liguria, 16147, Italy
-
Multicare Institute for Research and Innovation
Tacoma, Washington, 98405, United States
-
Ospedale Pediatrico Bambino Gesù
Rome, Lazio, 00165, Italy
-
Queensland Children?s Hospital
South Brisbane, Queensland, 4101, Australia
-
Rush Medical Center
Chicago, Illinois, 60612, United States
-
Vanderbilt Children's Hospital
Nashville, Tennessee, 37232-9119, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can early parent coaching help infants with rare genetic disorders thrive?
- Newborn screening study aims to catch rare diseases at birth
- New hope for angelman syndrome: drug trial targets brain function
- New registry aims to shed light on angelman syndrome
- New study tracks angelman syndrome progression in kids and adults
- 2000-Patient study aims to uncover hidden metabolic risks in rare genetic disorders